Posters
(results will display both Free Papers & Poster)
ReLEx SMILE and femtoLASIK in lower and higher myopia
Poster Details
First Author: J.Kacerovska CZECH REPUBLIC
Co Author(s): M. Kacerovsky R. Havranek
Abstract Details
Purpose:
The goal of this study was to evaluate the results and the efficiency of laser interventions where we use the femtosecond laser – FS-LASIK and ReLEx SMILE. We performed a retrospective data analysis by comparing the post-operational visual acuity development in a group of one hundred patients with lower and higher myopia and astigmatism.
Setting:
Eye clinic Horní Pocernice,Prague, Czech republic
Methods:
The studied cohort of patients consisted of two groups. The first group included patients with lower myopia and the second group included patients with higher myopia. In each group, one half of the patients underwent the femtoLASIK and the other half underwent the ReLEx SMILE. We observed 50 patients (100 eyes) with lower myopia and 50 patients (100 eyes) with higher myopia. In the retrospective data analysis, we included patients younger than 45 years with the spherical equivalent of the myopic refractive error ranging from -0,75 to -4,12 in first group and ranging from -6,25 to -11,5 in second group.
Results:
During post-surgical check-ups, the values of uncorrected visual acuity in the group of patients with lower myopia were similar in both femtoLASIK and ReLEx SMILE methods. On the other hand, in the group of patients with higher myopia and measured shortly after the interventions, the values of uncorrected visual acuity were lower in the ReLEx SMILE method. However, after one year, the ReLEx SMILE method shows better values of uncorrected visual acuity than the femtoLASIK method.
Conclusions:
This study pointed out the comparability of post-operational refractive results, concerning the correction of lower myopia, and favoured the ReLEx SMILE method concerning the correction of higher myopia, mainly thanks to the stability of visual acuity during longer observation periods.
Financial Disclosure:
None